Marc Goodman Analyst PerformanceAnalyst at Seaport Research PartnersMarc Goodman is a stock analyst at Seaport Research Partners in the healthcare sector, covering 28 publicly traded companies. Over the past year, Marc Goodman has issued 17 stock ratings, including and buy recommendations. While full access to Marc Goodman's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Marc Goodman's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access to unlock analyst rankings MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings53 Last 11 YearsBuy Recommendations79.25% 42 Buy RatingsCompanies Covered28 Unique Companies Ratings Distribution53RatingsDistribution of strong buy, buy, hold, and sell ratings by Marc Goodman.RatingPercentageCount Strong Buy0.0%0 ratings Buy79.2%42 ratings Hold20.8%11 ratings Sell0.0%0 ratingsOut of 53 total stock ratings issued by Marc Goodman at Seaport Research Partners, the majority (79.2%) have been Buy recommendations, followed by 20.8% Hold.Best & Worst CallsBest Call0000.0%EOLSApr 2020Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%BHCDec 2015Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ67.9% of companies on NASDAQ19 companiesNYSE32.1% of companies on NYSE9 companiesMarc Goodman, an analyst at Seaport Research Partners, currently covers 28 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare28 companies100.0%Marc Goodman of Seaport Research Partners specializes in stock coverage within the Healthcare sector.Coverage IndustriesIndustryPercentagePHARMACEUTICALS19 companies67.9%BIOTECHNOLOGY9 companies32.1% Marc Goodman's Ratings History at Seaport Research Partners Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter More filters Fewer filters Done 0 Results Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsMANEVeradermics11/9/2026Boost Price Target$143.44$150.00Outperform$0.0000.00% ROINGENNervGen Pharma7/13/2026Initiated Coverage$1.88$10.00Outperform$0.0000.00% ROIRAPPRapport Therapeutics6/24/2026Initiated Coverage$38.88$52.00Outperform$0.0000.00% ROIDFTXDefinium Therapeutics6/22/2026Set Price Target$37.55$52.00Outperform$0.0000.00% ROISPTXSeaport Therapeutics5/26/2026Initiated Coverage$17.50$35.00Outperform$0.0000.00% ROIDNLIDenali Therapeutics4/22/2026Lower Price Target$20.42$35.00Outperform$0.0000.00% ROIDFTXDefinium Therapeutics4/22/2026Boost Price Target$22.83$30.00Outperform$0.0000.00% ROINBIXNeurocrine Biosciences4/22/2026Boost Price Target$130.76$170.00Outperform$0.0000.00% ROIMANEVeradermics4/22/2026Boost Price Target$76.09$90.00Outperform$0.0000.00% ROIJAZZJazz Pharmaceuticals4/22/2026Boost Price Target$201.27$225.00Outperform$0.0000.00% ROIBHVNBiohaven3/3/2026Reiterated Rating$10.66$15.00Outperform$0.0000.00% ROISGPSpyglass Pharma3/3/2026Initiated Coverage$26.73$42.00Outperform$0.0000.00% ROIMANEVeradermics3/2/2026Initiated Coverage$45.70$75.00Outperform$0.0000.00% ROIAXSMAxsome Therapeutics1/28/2026Boost Price Target$184.56$205.00Outperform$0.0000.00% ROINMRANeumora Therapeutics1/12/2026Initiated Coverage$2.22$8.00Outperform$0.0000.00% ROIMPLTMaplight Therapeutics11/21/2025Initiated Coverage$13.29$30.00Outperform$0.0000.00% ROIOVIDOvid Therapeutics11/17/2025Initiated Coverage$1.31$5.00Outperform$0.0000.00% ROIAVDLAvadel Pharmaceuticals10/23/2025Reiterated Rating$18.56$18.50Market Perform$0.0000.00% ROILBRXLB Pharmaceuticals10/6/2025Initiated Coverage$15.05$34.00Outperform$00.0000.00% ROIBHVNBiohaven8/12/2025Lower Price Target$13.46$50.00Outperform$00.0000.00% ROIAMLXAmylyx Pharmaceuticals5/7/2025Upgrade$4.65$10.00Outperform$00.0000.00% ROIOPTOpthea3/25/2025Downgrade$3.41$1.00Market Perform$0.0000.00% ROIAXSMAxsome Therapeutics2/10/2025Boost Price Target$127.08$150.00Outperform$000.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysRoyal Bank Of CanadaWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche Bank AktiengesellschaftBMO Capital MarketsRaymond James Financial Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
